.jpg)
IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF BREAST CANCER
Patent number:
EP21382448
No items found.
The present invention refers to an in vitro method for the diagnosis and/or prognosis of breast cancer. The method of the invention is carried out by determining the concentration level of proteins in erythrocytes or red blood cells (RBCs) comprised in patient blood samples.
Countries:
Spain
Regions:
Galicia
Centers:
SERVIZO GALEGO DE SAUDE, UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, OTHER
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
These types of biomarkers could help detecting metastatic breast cancer early and non-invasively, reducing costs and influencing directly on the patients quality of life. These biomarkers would allow to adapt the treatments to the phase of the disease, avoiding unnecessary treatments and reducing the levels of toxicity or secondary effects.
Comments